Skip to main content
Log in

Astatine-211 labeling: a study towards automatic production of astatinated antibodies

  • Published:
Journal of Radioanalytical and Nuclear Chemistry Aims and scope Submit manuscript

Abstract

Targeted alpha therapy is especially interesting for therapy of microscopic cancer tumors due to short path length and high linear energy transfer of the alpha particles. One of the most promising nuclides for targeted alpha therapy is 211At. To facilitate larger clinical studies using 211At, the current manual synthesis of radiolabeled antibodies would benefit from being transferred into an automated method. In this work, successful modifications of the manual synthesis have been performed in order to adapt it to automation. The automatic synthesis has also been tested using the modified synthesis method.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Elgqvist J, Frost S, Pouget J-P, Albertsson P (2014) Front Oncol 3(324):1–9

    Google Scholar 

  2. Choppin G, Liljenzin J-O, Rydberg J (2002) Radiochemistry and Nuclear Chemistry. Butterworth-Heinemann, Woburnn

    Google Scholar 

  3. Kim Y-S, Brechbiel MW (2012) Tumor Biol 33:573–590

    Article  CAS  Google Scholar 

  4. Rajpar S, Fizazi K (2013) Cancer J 19:66–70

    Article  CAS  Google Scholar 

  5. Huclier-Markai S, Alliot C, Varmenot N, Cutler CS, Barbet J (2013) Curr Top Med Chem 23:2642–2654

    Article  Google Scholar 

  6. Kassis AI, Harris CR, Adelstein SJ (1986) Radiat Res 105:27–36

    Article  CAS  Google Scholar 

  7. Elgqvist J, Andersson H, Bäck T, Hultborn R, Jensen H, Karlsson B, Lindegren S, Palm S, Warnhammar E, Jacobsson L (2005) J Nucl Med 46:1907–1915

    CAS  Google Scholar 

  8. Elgqvist J, Andersson H, Bäck T, Claesson I, Hultborn R, Jensen H, Johansson BR, Lindegren S, Olsson M, Palm S, Warnhammar E, Jacobsson L (2006) J Nucl Med 47:1342–1350

    CAS  Google Scholar 

  9. Bäck T, Haraldsson B, Hultborn R, Jensen H, Johansson ME, Lindegren S, Jacobsson L (2009) Cancer Biother Radiopharm 24:649–658

    Article  Google Scholar 

  10. Andersson H, Cederkrantz E, Bäck T, Divgi C, Elgqvist J, Himmelman J (2009) J Nucl Med 50:1153–1160

    Article  CAS  Google Scholar 

  11. Cederkrantz E (2014) Doctoral thesis available at: http://hdl.handle.net/2077/34850. Accessed 27 June 2014

  12. Zalutsky MR, Zhao X-G, Alston KL, Bigner D (2001) J Nucl Med 42:1508–1515

    CAS  Google Scholar 

  13. Lindegren S, Frost S, Bäck T, Haglund E, Elgqvist J, Jensen H (2008) J Nucl Med 49:1537–1545

    Article  CAS  Google Scholar 

  14. Lambert JL, Ramasamy J, Paukstelis JV (1975) Anal Chem 47:916–918

    Article  CAS  Google Scholar 

  15. Li CH, White CF (1943) J Am Chem Soc 65:335–339

    Article  CAS  Google Scholar 

  16. Beebe TR, Adkins M, Kwok P, Roehm R (1972) J Org Chem 37:4220–4222

    Article  CAS  Google Scholar 

  17. Horacek J, Skladal P (1998) Chem Pap 52:294–295

    CAS  Google Scholar 

Download references

Acknowledgments

The Inga Britt and Arne Lundbergs Research Foundation, The Swedish Cancer Society and the King Gustaf V Jubilee Clinic Research Foundation are acknowledged for the funding of this work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Emma Aneheim.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aneheim, E., Jensen, H., Albertsson, P. et al. Astatine-211 labeling: a study towards automatic production of astatinated antibodies. J Radioanal Nucl Chem 303, 979–983 (2015). https://doi.org/10.1007/s10967-014-3561-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10967-014-3561-8

Keywords

Navigation